Carcinoma In Situ — Trials

Carcinoma In Situ — Trials · CancerIndex

Clinical trials

Registered studies

274 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 72
Recruiting: 35
Ph III recruiting: 4
Growth YoY: —
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (41)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02698293	PDT Plus Vitamin D3 for Anal Dysplasia	withdrawn	Phase 1	0	Abramson Cancer Center at Penn MedicineOTHER	1	Aug 4, 2026	clinicaltrials
NCT02856503	Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors	withdrawn	Phase 1 / Phase 2	0	Eli Avisar, MDOTHER	0	Apr 17, 2026	clinicaltrials